1. Home
  2. RARE vs WU Comparison

RARE vs WU Comparison

Compare RARE & WU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RARE
  • WU
  • Stock Information
  • Founded
  • RARE 2010
  • WU 1851
  • Country
  • RARE United States
  • WU United States
  • Employees
  • RARE N/A
  • WU N/A
  • Industry
  • RARE Biotechnology: Pharmaceutical Preparations
  • WU Business Services
  • Sector
  • RARE Health Care
  • WU Consumer Discretionary
  • Exchange
  • RARE Nasdaq
  • WU Nasdaq
  • Market Cap
  • RARE 3.5B
  • WU 3.3B
  • IPO Year
  • RARE 2014
  • WU 2006
  • Fundamental
  • Price
  • RARE $39.91
  • WU $8.61
  • Analyst Decision
  • RARE Strong Buy
  • WU Hold
  • Analyst Count
  • RARE 15
  • WU 10
  • Target Price
  • RARE $90.53
  • WU $11.19
  • AVG Volume (30 Days)
  • RARE 1.1M
  • WU 8.6M
  • Earning Date
  • RARE 07-31-2025
  • WU 07-29-2025
  • Dividend Yield
  • RARE N/A
  • WU 10.90%
  • EPS Growth
  • RARE N/A
  • WU 59.38
  • EPS
  • RARE N/A
  • WU 2.70
  • Revenue
  • RARE $590,689,000.00
  • WU $4,144,200,000.00
  • Revenue This Year
  • RARE $18.94
  • WU $1.12
  • Revenue Next Year
  • RARE $28.93
  • WU $1.69
  • P/E Ratio
  • RARE N/A
  • WU $3.20
  • Revenue Growth
  • RARE 33.46
  • WU N/A
  • 52 Week Low
  • RARE $29.59
  • WU $8.29
  • 52 Week High
  • RARE $60.37
  • WU $13.12
  • Technical
  • Relative Strength Index (RSI)
  • RARE 65.02
  • WU 40.39
  • Support Level
  • RARE $35.51
  • WU $8.29
  • Resistance Level
  • RARE $38.19
  • WU $8.76
  • Average True Range (ATR)
  • RARE 1.58
  • WU 0.22
  • MACD
  • RARE 0.20
  • WU 0.04
  • Stochastic Oscillator
  • RARE 98.43
  • WU 41.25

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

About WU Western Union Company (The)

Western Union provides domestic and international money transfers through its global network of over 500,000 outside agents. The company handled almost 290 million transactions in 2024 and is the largest money transfer company in the world.

Share on Social Networks: